nab-paclitaxel,177lu-psma-617,lutetium-177 psma-i&t,ipilimumab,gemcitabine,radium-223,apx005m,nivolumab,pembrolizumab,cabazitaxel,olaparib
merck,bms,novartis,apexigen,astrazeneca,bayer
['prince,(-princes)', 'luparp', 'nivo', 'pembro', 'alphabet', 'ipi/', 'lucab']
great to see other lu-psma combo studies highlighted by #asco23 during discussion on luparp evolution (+/- ipi/nivo) prince (+pembro), alphabet (+ra-223) &amp; lucab (+cabazi) 
GU Med Onc, A/Prof Peter Mac/UoM, ANZUP Translational Chair, #UpfrontPSMA Alliance, COSA Urologic Oncology Chair, NHMRC L1 Investigator. Opinions my own.